The release of the snapshot containing the respective simulations can be found here:
https://github.com/Open-Systems-Pharmacology/Erythromycin-Alprazolam-DDI/releases/tag/v1.2

The erythromycin-alprazolam interaction was evaluated using one clinical DDI study ([Yasui 1996](#4-references)).



| DataID | Enzyme | Perpetrator / victim      | Study design                                                 | Clinical study              |
| ------ | ------ | ------------------------- | ------------------------------------------------------------ | --------------------------- |
| 777    | CYP3A4 | Erythromycin / alprazolam | Erythromycin: 400 mg po TID for 10 days (filmcoated tablet containing erythromycin stearate)<br />Alprazolam: 0.8 mg po single dose, 2 hours after the 22<sup>nd</sup> erythromycin dose | [Yasui 1996](#4-references) |


